Impact of anti-VEGF therapy on distinctive retina layers in patients with macular edema secondary to branch retinal vein occlusion
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Impact of anti-VEGF therapy on distinctive retina layers in patients with macular edema secondary to branch retinal vein occlusion ; volume:23 ; number:1 ; day:25 ; month:5 ; year:2023 ; pages:1-9 ; date:12.2023
BMC ophthalmology ; 23, Heft 1 (25.5.2023), 1-9, 12.2023
- Creator
-
Wang, Hui
Wang, Chanjuan
Zhang, Shaochi
Liu, Jun
Bi, Xiaojun
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12886-023-02981-7
- URN
-
urn:nbn:de:101:1-2023091013132357264124
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, Hui
- Wang, Chanjuan
- Zhang, Shaochi
- Liu, Jun
- Bi, Xiaojun
- SpringerLink (Online service)
Other Objects (12)
Retinal venous pressure is decreased after anti-VEGF therapy in patients with retinal vein occlusion–related macular edema
Anti-VEGF for the management of diabetic macular edema
Vitreomacular interface after anti-VEGF injections in diabetic macular edema
Switch of intravitreal therapy for macular edema secondary to retinal vein occlusion from Anti-VEGF to dexamethasone implant and vice versa
Ranibizumab for macular edema secondary to retinal vein occlusion: a meta-analysis of dose effects and comparison with no anti-VEGF treatment
Real-life study of the use of anti-VEGF therapy versus dexamethasone implant for treatment of macular edema in retinal vein occlusion
Temporal diabetes-induced biochemical changes in distinctive layers of mouse retina
Mature vessel occlusion after anti-VEGF treatment in a retinal arteriovenous malformation
Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
Efficacy and effectiveness of anti-VEGF or steroids monotherapy versus combination treatment for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis
Visual and anatomic outcomes of sustained single agent anti-VEGF treatment versus double anti-VEGF switching in the treatment of persistent diabetic macular edema
Investigation of choroidal structure changes after intravitreal anti-VEGF therapy for retinal vein occlusion
Retinal venous pressure is decreased after anti-VEGF therapy in patients with retinal vein occlusion–related macular edema
Anti-VEGF for the management of diabetic macular edema
Vitreomacular interface after anti-VEGF injections in diabetic macular edema
Switch of intravitreal therapy for macular edema secondary to retinal vein occlusion from Anti-VEGF to dexamethasone implant and vice versa
Ranibizumab for macular edema secondary to retinal vein occlusion: a meta-analysis of dose effects and comparison with no anti-VEGF treatment
Real-life study of the use of anti-VEGF therapy versus dexamethasone implant for treatment of macular edema in retinal vein occlusion
Temporal diabetes-induced biochemical changes in distinctive layers of mouse retina
Mature vessel occlusion after anti-VEGF treatment in a retinal arteriovenous malformation
Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
Efficacy and effectiveness of anti-VEGF or steroids monotherapy versus combination treatment for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis
Visual and anatomic outcomes of sustained single agent anti-VEGF treatment versus double anti-VEGF switching in the treatment of persistent diabetic macular edema
Investigation of choroidal structure changes after intravitreal anti-VEGF therapy for retinal vein occlusion
Retinal venous pressure is decreased after anti-VEGF therapy in patients with retinal vein occlusion–related macular edema
Anti-VEGF for the management of diabetic macular edema
Vitreomacular interface after anti-VEGF injections in diabetic macular edema
Switch of intravitreal therapy for macular edema secondary to retinal vein occlusion from Anti-VEGF to dexamethasone implant and vice versa
Ranibizumab for macular edema secondary to retinal vein occlusion: a meta-analysis of dose effects and comparison with no anti-VEGF treatment
Real-life study of the use of anti-VEGF therapy versus dexamethasone implant for treatment of macular edema in retinal vein occlusion
Temporal diabetes-induced biochemical changes in distinctive layers of mouse retina
Mature vessel occlusion after anti-VEGF treatment in a retinal arteriovenous malformation
Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
Efficacy and effectiveness of anti-VEGF or steroids monotherapy versus combination treatment for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis
Visual and anatomic outcomes of sustained single agent anti-VEGF treatment versus double anti-VEGF switching in the treatment of persistent diabetic macular edema